More importantly, DHM reversed TAA-induced liver fibrosis by inhibiting NF-κB-mediated inflammation and TGF-β1-regulated apoptotic proteins downstream of the PI3K/Akt signalling pathway, which also indicated that DHM may be a potential active substance against chronic liver disease (Figure 7). The gene discussed is NFKB1; the disease is Hepatic fibrosis.